RYAN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ryan Specialty Holdings Inc (RYAN) does not present a compelling buy opportunity for a beginner investor with a long-term strategy at this time. Despite hedge fund buying activity and a slight pre-market price increase, the company's financial performance shows significant declines in net income and EPS. Analyst ratings have been largely neutral to negative, with multiple price target reductions. Additionally, no strong trading signals or recent positive news catalysts are present to support a buy decision.
The MACD is positively expanding with a histogram of 0.706, indicating bullish momentum. However, the RSI at 79.51 suggests the stock is nearing overbought territory. Moving averages are converging, showing no clear trend. Key resistance is at 37.239 and 38.53, while support levels are at 33.06 and 31.769. The stock is trading near resistance, limiting upside potential in the short term.
Hedge funds are significantly increasing their positions, with a 53579.79% rise in buying activity over the last quarter. The MACD indicates bullish momentum.
Analysts have consistently lowered price targets, citing soft market conditions and pricing pressures. No recent news or congress trading data to support a positive sentiment.
In Q4 2025, revenue grew by 13.21% YoY to $751.2M, but net income dropped to $7.98M (-47.13% YoY), and EPS fell to 0.06 (-111.76% YoY). Gross margin remained unchanged.
Analyst sentiment is mixed to negative. Several firms, including JPMorgan, Mizuho, and Cantor Fitzgerald, have lowered price targets, citing challenges in the insurance sector. While some analysts maintain Buy or Overweight ratings, the overall sentiment reflects caution due to pricing pressures and sluggish growth in the sector.
